source
- Merck R&D chief says company has outpaced rivals with its sac-TMT cancer platformDean Li, the head of Merck Research Laboratories, said the company believes its sac-TMT cancer program gives it a competitive edge over other firms developing next-generation oncology therapies. T…
- Federal rule forces PBMs to disclose fees and rebates to employersThe Trump administration finalized a regulation that will require pharmacy benefit managers (PBMs) to reveal the various fees and compensation they receive from drugmakers, consultants and other pa…